The National Health Service (General Medical Services) (Scotland) Amendment Regulations 2003
Citation, commencement and interpretation1.
(1)
These Regulations may be cited as the National Health Service (General Medical Services) (Scotland) Amendment Regulations 2003 and shall come into force on 1st February 2003.
(2)
Amendment of Schedule 10 to the principal Regulations2.
In Schedule 10 to the principal Regulations (drugs and other substances not to be supplied by general medical practitioners or prescribed for supply under pharmaceutical services) the following entries shall be deleted:–
Fabrol Granules
Fluimucil Granules
Methylcisteine Tablets 100 mg
Mucodyne Capsules
Mucodyne Forte Syrup
Mucodyne Forte Tablets
Mucodyne Paediatric Syrup
Mucodyne Syrup
Visclair Tablets
Amendment of Schedule 11 to the principal Regulations3.
In Schedule 11 to the principal Regulations (drugs to be supplied by general medical practitioners or prescribed for supply under pharmaceutical services only in certain circumstances)–
(a)
the following entries shall be deleted:–
“Acetylcysteine Granules” in column 1 and the entries in columns 2 and 3 which relate to that entry;
“Carbocisteine” in column 1 and the entries in columns 2 and 3 which relate to that entry; and
- (a)
after the entry “Moxisylyte Hydrochloride (Erecnos)” in each of columns 1 and 2 there is inserted “Tadalafil (Cialis)”.
- (a)
St Andrew’s House, Edinburgh
These Regulations amend the National Health Service (General Medical Services) (Scotland) Regulations 1995 (“the principal Regulations”) which regulate the terms on which doctors provide general medical services under the National Health Service (Scotland) Act 1978 (“the 1978 Act”).
Regulation 2 removes 9 products from Schedule 10 to the principal Regulations, which identifies those drugs and other substances which are not to be supplied by general medical practitioners or prescribed for supply in the course of pharmaceutical services under the 1978 Act.
Regulation 3(a) removes 2 products from, and regulation 3(b) adds 1 product to, Schedule 11 to the principal Regulations, which identifies those drugs which may be supplied by general medical practitioners or prescribed for supply under pharmaceutical services only in certain circumstances.